Orbactiv (oritavancin) is administered as what type of dose?

Orbactiv (oritavancin) is designed to be administered as a single-dose infusion. This distinguishes it from other treatments that require multiple doses or ongoing administration. The formulation and dosing schedule of Orbactiv have been specifically developed to allow for an effective treatment within a single administration, which simplifies the treatment process for patients and healthcare providers.

Using a single-dose infusion means that the medication can be delivered in one session, leading to enhanced patient compliance and convenience. This approach is particularly beneficial for those who may have difficulty adhering to a multi-day regimen or who might require hospitalization for more frequent dosing.

The other options imply either continuous or multiple dosing strategies, which do not apply to Orbactiv's pharmacological management. The single-dose design is a key aspect of its clinical utility, allowing for effective treatment of infections with a single administration.